Authors
Loading...
Randomized trial evaluates the inhibition of cholinesterase in synthetic benzimidazole derivatives, implying their potential in treating Alzheimer's disease.
Shakoor et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: